By Baris Gencer, et al. − Proprotein convertase subtilisin kexin 9 (PCSK9) is a promising target in the management of lipid disorders. PCSK9 inhibition offers a novel therapeutic mechanism for the lowering of low-density lipoprotein cholesterol … [read more ...]
By Philipp Schütz – Malnutrition is a major issue in hospital care. Whether, how and why early nutritional therapy affects outcomes of unselected, elderly, frail medical inpatients remains largely unclear today. Should physicians indeed encourage … [read more...]
By Christel Tran, et al. − Peripheral neuropathies are well-known complications of diabetes. Acute painful diabetic neuropathy (APDN), one of the less common types, is associated with the rapid decrease of high glycaemic levels. This article … [read more ...]
Since the Swiss Academy of Medical Sciences (SAMS) guidelines on “Borderline questions in intensive-care medicine” were first published in 1999, medicine’s capacity to keep patients alive through technological and pharmacological interventions has been substantially enhanced.
By Andreas Valentin − “Not the application of intensive care measures but the decision about their appropriateness is the most challenging aspect of modern intensive care medicine.” Many experienced intensive care physicians will confirm this statement, although it may be true for other highly invasive and demanding medical areas as well.
By Adriano Aguzzi − It has taken a while, but the Swiss Academies of Arts and Sciences (SAAS) have come out with a valuable booklet on authorships of scientific manuscripts. This recommendations, published now also as a special article in the Swiss Medical Weekly, aspire to serve as a practical guide for principal investigators confronted […]